patients pfizers-initiative-return-clinical-trial-data-patients 
pharmaphorum
JANUARY 6, 2023
The UK has formed an partnership with German biotech BioNTech to provide up to 10,000 patients with access to personalised cancer therapies, in another example of the country embracing the mRNA technologies that underpinned COVID-19 vaccines. The post UK partners with BioNTech on clinical trials of mRNA cancer therapies appeared first on.
pharmaphorum
JUNE 1, 2021
Pharmaceutical companies are accountable for ensuring that their medicine is safe when it comes into the hands of patients. Specific apps could also alert healthcare providers if vulnerable patients are failing to scan their medicine. This technology can also play an important role in supporting virtual clinical trials.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
NOVEMBER 12, 2020
Interim analysis of the COVID-19 vaccine candidate Pfizer has been working on with BioNTech found it to be more than 90% effective at countering the disease, and the company said it expected to be in a position to file BNT162b2 for FDA approval in the third week of November.
pharmaphorum
MAY 17, 2021
In the following, we summarise the situation one year on from the pandemic with updated quantitative data, and qualitative research with physicians in Europe, to bring the all-important ‘voice of the customer’ to the debate around ‘what next?’. Analysis of Net Promoter Score in IQVIA’s ChannelDynamics data presents some interesting findings.
Pharma Marketing Network
APRIL 30, 2021
Clinical trials may be one of the very last bastions of a non-customer-focused approach within the pharmaceutical industry. Protocols, which have remained substantively unchanged for over 30 years, often impose an immense burden on patient participants, largely due to the frequency of site visits.
pharmaphorum
FEBRUARY 8, 2022
We live in a diverse world and our teams, clinical trial participants, customers, and key opinion leaders (KOLs) should reflect this. Diversity in clinical trials. Racial disparities are still commonplace in most clinical trials. Are decentralised and virtual trials the answer? Diverse teams.
Hospital Pharmacy Europe
AUGUST 22, 2023
As an overseas student, for me, having to deal face-to-face with patients using a second language wasn’t that easy,’ he explains. As a result, he quickly developed the necessary skills to communicate effectively with both patients and doctors – something he believes ‘benefitted me for the rest of my life’.
Expert insights. Personalized for you.
107 
Let's personalize your content